BioCentury
ARTICLE | Financial News

Braeburn withdraws IPO

February 3, 2017 8:42 PM UTC

On Feb. 2, neurology company Braeburn Pharmaceuticals Inc. (Princeton, N.J.) said it will withdraw its IPO on NASDAQ, citing “significant available capital” and market conditions....

BCIQ Company Profiles

Braeburn Pharmaceuticals Inc.